Aehr Test Systems (AEHR) Analysts See $-0.04 EPS, CITIUS PHARMACEUTICALS (CTXR) Shorts Raised By 6.45%

June 29, 2017 - By Maria Brooks

CITIUS PHARMACEUTICALS INCORPORATED (OTCMKTS:CTXR) had an increase of 6.45% in short interest. CTXR’s SI was 3,300 shares in June as released by FINRA. Its up 6.45% from 3,100 shares previously. With 51,300 avg volume, 0 days are for CITIUS PHARMACEUTICALS INCORPORATED (OTCMKTS:CTXR)’s short sellers to cover CTXR’s short positions. The stock decreased 0.32% or $0.02 on June 28, reaching $6.31. About 6,318 shares traded or 27.20% up from the average. Citius Pharmaceuticals Inc (OTCMKTS:CTXRD) has 0.00% since June 29, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts expect Aehr Test Systems (NASDAQ:AEHR) to report $-0.04 EPS on July, 25.They anticipate $0.19 EPS change or 82.61% from last quarter’s $-0.23 EPS. After having $-0.16 EPS previously, Aehr Test Systems’s analysts see -75.00% EPS growth. The stock decreased 3.05% or $0.12 on June 28, reaching $3.82. About shares traded. Aehr Test Systems (NASDAQ:AEHR) has risen 308.65% since June 29, 2016 and is uptrending. It has outperformed by 291.95% the S&P500.

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company has market cap of $32.32 million. The Firm is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. It currently has negative earnings. The Company’s product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream.

Investors sentiment decreased to 1.67 in 2016 Q4. Its down 0.08, from 1.75 in 2016Q3. It fall, as 2 investors sold Aehr Test Systems shares while 1 reduced holdings. 0 funds opened positions while 5 raised stakes. 1.59 million shares or 1.97% more from 1.55 million shares in 2016Q3 were reported. Renaissance Lc owns 75,100 shares or 0% of their US portfolio. Blackrock Fund Advsrs holds 0% or 4,011 shares in its portfolio. Geode Capital Management Ltd Llc holds 0% or 82,292 shares in its portfolio. Minerva Advisors Llc stated it has 0.07% in Aehr Test Systems (NASDAQ:AEHR). Vanguard, Pennsylvania-based fund reported 127,303 shares. 20,057 were reported by Deutsche Bancorp Ag. Raymond James Fincl Service Advsr Inc holds 0% of its portfolio in Aehr Test Systems (NASDAQ:AEHR) for 155,971 shares. Morgan Stanley owns 19,669 shares. Awm Communication invested in 0.5% or 1.05 million shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.